NDC 24208-353

Alrex

Loteprednol Etabonate

Alrex is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Loteprednol Etabonate.

Product ID24208-353_138577af-1a4e-48fb-b088-47f54c896442
NDC24208-353
Product TypeHuman Prescription Drug
Proprietary NameAlrex
Generic NameLoteprednol Etabonate
Dosage FormSuspension/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date1998-03-09
Marketing CategoryNDA / NDA
Application NumberNDA020803
Labeler NameBausch & Lomb Incorporated
Substance NameLOTEPREDNOL ETABONATE
Active Ingredient Strength2 mg/mL
Pharm ClassesCorticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 24208-353-01

1 BOTTLE, DROPPER in 1 CARTON (24208-353-01) > 1 mL in 1 BOTTLE, DROPPER
Marketing Start Date1998-03-09
NDC Exclude FlagN
Sample Package?Y

NDC SPL Data Element Entries

NDC 24208-353-05 [24208035305]

ALREX SUSPENSION/ DROPS
Marketing CategoryNDA
Application NumberNDA020803
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1998-03-09

NDC 24208-353-10 [24208035310]

ALREX SUSPENSION/ DROPS
Marketing CategoryNDA
Application NumberNDA020803
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1998-03-09

NDC 24208-353-25 [24208035325]

ALREX SUSPENSION/ DROPS
Marketing CategoryNDA
Application NumberNDA020803
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-04-08
Marketing End Date2013-04-12

NDC 24208-353-01 [24208035301]

ALREX SUSPENSION/ DROPS
Marketing CategoryNDA
Application NumberNDA020803
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1998-03-09

Drug Details

Active Ingredients

IngredientStrength
LOTEPREDNOL ETABONATE2 mg/mL

OpenFDA Data

SPL SET ID:21c76da0-50a1-41c0-91b8-8cc4dcc27f60
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 213262
  • 311381
  • Pharmacological Class

    • Corticosteroid [EPC]
    • Corticosteroid Hormone Receptor Agonists [MoA]

    Medicade Reported Pricing

    24208035310 ALREX 0.2% EYE DROPS

    Pricing Unit: ML | Drug Type:

    24208035305 ALREX 0.2% EYE DROPS

    Pricing Unit: ML | Drug Type:

    NDC Crossover Matching brand name "Alrex" or generic name "Loteprednol Etabonate"

    NDCBrand NameGeneric Name
    24208-353Alrexloteprednol etabonate
    71571-333Eysuvisloteprednol etabonate
    71571-121Inveltysloteprednol etabonate
    24208-299LOTEMAXloteprednol etabonate
    24208-443Lotemaxloteprednol etabonate
    24208-503LOTEMAXloteprednol etabonate
    24208-507Lotemax SMloteprednol etabonate
    17478-830Loteprednol EtabonateLoteprednol Etabonate
    24208-508Loteprednol Etabonateloteprednol etabonate
    50383-265Loteprednol EtabonateLoteprednol Etabonate
    62756-232Loteprednol EtabonateLoteprednol Etabonate
    68682-299Loteprednol Etabonateloteprednol etabonate

    Trademark Results [Alrex]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ALREX
    ALREX
    75442434 2360654 Dead/Cancelled
    BAUSCH & LOMB INCORPORATED
    1998-03-02
    ALREX
    ALREX
    75283586 2265425 Live/Registered
    BAUSCH & LOMB INCORPORATED
    1997-04-29
    ALREX
    ALREX
    72325406 0887079 Dead/Expired
    KENNETH SMITH, INC.
    1969-04-23

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.